Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Murrell

Showing results (361-370 of 490) with videos related to

Pageof 49
Sort By:
Acta Dermato-Venereologica|June 29, 2026
A Cross-sectional Study on Quality of Life in EB: Validation of the Italian QOLEB and Assessment in Italian PatientsGiovanna Zambruno, Tonia Samela, Andrea Diociaiuti, et al.
Clinical and Experimental Dermatology|September 8, 2010
Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigusD F Sebaratnam, L K Martin, A I Rubin, et al.
International Journal of Dermatology|October 17, 2015
Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian PortugueseTania Cestari, Clarissa Prati, Doris B Menegon, et al.
Archives of Dermatology|June 23, 2010
Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosaYong Chern Kho, Lesley M Rhodes, Susan J Robertson, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 1, 1997
Modulation of tendon healing by nitric oxideG A Murrell, C Szabo, J A Hannafin, et al.
Italian Journal of Pediatrics|April 18, 2024
"Quality of Life in Epidermolysis Bullosa" and "Epidermolysis Bullosa Burden of Disease": Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnairesMay El Hachem, Andrea Diociaiuti, Giovanna Zambruno, et al.
Nature Communications|January 10, 2015
Innate sensing of microbial products promotes wound-induced skin cancerEsther Hoste, Esther N Arwert, Rohit Lal, et al.
The British Journal of Dermatology|December 25, 2016
A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patientsC Y Zhao, E Y Hao, D D Oh, et al.
Journal of the American Academy of Dermatology|December 3, 2023
The road to publication: Advice from journal editorsCristian Navarrete-Dechent, Karalikkattil T Ashique, John R Ingram, et al.
Orphanet Journal of Rare Diseases|June 25, 2020
Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)Amy S Paller, John Browning, Milos Nikolic, et al.
Pageof 49

Showing results (361-370 of 490) with videos related to

Sort By:
Pageof 49
Acta Dermato-Venereologica|June 29, 2026
A Cross-sectional Study on Quality of Life in EB: Validation of the Italian QOLEB and Assessment in Italian PatientsGiovanna Zambruno, Tonia Samela, Andrea Diociaiuti, et al.
Clinical and Experimental Dermatology|September 8, 2010
Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigusD F Sebaratnam, L K Martin, A I Rubin, et al.
International Journal of Dermatology|October 17, 2015
Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian PortugueseTania Cestari, Clarissa Prati, Doris B Menegon, et al.
Archives of Dermatology|June 23, 2010
Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosaYong Chern Kho, Lesley M Rhodes, Susan J Robertson, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 1, 1997
Modulation of tendon healing by nitric oxideG A Murrell, C Szabo, J A Hannafin, et al.
Italian Journal of Pediatrics|April 18, 2024
"Quality of Life in Epidermolysis Bullosa" and "Epidermolysis Bullosa Burden of Disease": Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnairesMay El Hachem, Andrea Diociaiuti, Giovanna Zambruno, et al.
Nature Communications|January 10, 2015
Innate sensing of microbial products promotes wound-induced skin cancerEsther Hoste, Esther N Arwert, Rohit Lal, et al.
The British Journal of Dermatology|December 25, 2016
A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patientsC Y Zhao, E Y Hao, D D Oh, et al.
Journal of the American Academy of Dermatology|December 3, 2023
The road to publication: Advice from journal editorsCristian Navarrete-Dechent, Karalikkattil T Ashique, John R Ingram, et al.
Orphanet Journal of Rare Diseases|June 25, 2020
Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)Amy S Paller, John Browning, Milos Nikolic, et al.
Pageof 49